SERPINB11 and ovarian carcinoma: A study by Lee et al. investigated the anticancer effects of eupatilin as a potential therapeutic agent directed at Serpinb11 in ovarian cancer cells, showing an inhibitory effect of eupatilin on Serpinb11 expression [29].